Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Yakushiji

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Neurology|March 20, 2026
Impact of Basal Ganglia Perivascular Spaces on Ischemic and Hemorrhagic Risks in Patients Taking Antithrombotic TherapiesSoya Iwamoto, Kaori Miwa, Masatoshi Koga, et al.
Environmental Health and Preventive Medicine|July 2, 2025
The Kashima Scan Study 2: a protocol for a prospective observational cohort study of cerebral small vessel disease in neurologically healthy adultsKohei Suzuyama, Yusuke Yakushiji, Akiko Matsumoto, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 20, 2021
Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trialKaori Miwa, Masatoshi Koga, Manabu Inoue, et al.
European Stroke Journal|February 18, 2021
The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participantsMasahito Takagi, Kanta Tanaka, Kaori Miwa, et al.
Journal of the American Heart Association|March 7, 2022
Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2Kanta Tanaka, Kaori Miwa, Masahito Takagi, et al.
European Journal of Neurology|June 2, 2026
Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic TherapyKaori Miwa, Masatoshi Koga, Kanta Tanaka, et al.
Geriatrics & Gerontology International|July 2, 2026
The Japanese Version of 26-Item Informant Questionnaire on Cognitive Decline in the Elderly: Development and Validation StudyMegumi Mizoguchi, Shuhei Ikeda, Yusuke Yakushiji, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2024
Cerebral small vessel disease markers and long-term prognosis in spontaneous intracerebral hemorrhage: the HAGAKURE-ICH studyShuhei Ikeda, Yusuke Yakushiji, Jun Tanaka, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 27, 2026
Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular DiseaseSohei Yoshimura, Kaori Miwa, Masatoshi Koga, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2022
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical TrialMasatoshi Koga, Manabu Inoue, Kaori Miwa, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Neurology|March 20, 2026
Impact of Basal Ganglia Perivascular Spaces on Ischemic and Hemorrhagic Risks in Patients Taking Antithrombotic TherapiesSoya Iwamoto, Kaori Miwa, Masatoshi Koga, et al.
Environmental Health and Preventive Medicine|July 2, 2025
The Kashima Scan Study 2: a protocol for a prospective observational cohort study of cerebral small vessel disease in neurologically healthy adultsKohei Suzuyama, Yusuke Yakushiji, Akiko Matsumoto, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 20, 2021
Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trialKaori Miwa, Masatoshi Koga, Manabu Inoue, et al.
European Stroke Journal|February 18, 2021
The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participantsMasahito Takagi, Kanta Tanaka, Kaori Miwa, et al.
Journal of the American Heart Association|March 7, 2022
Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2Kanta Tanaka, Kaori Miwa, Masahito Takagi, et al.
European Journal of Neurology|June 2, 2026
Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic TherapyKaori Miwa, Masatoshi Koga, Kanta Tanaka, et al.
Geriatrics & Gerontology International|July 2, 2026
The Japanese Version of 26-Item Informant Questionnaire on Cognitive Decline in the Elderly: Development and Validation StudyMegumi Mizoguchi, Shuhei Ikeda, Yusuke Yakushiji, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2024
Cerebral small vessel disease markers and long-term prognosis in spontaneous intracerebral hemorrhage: the HAGAKURE-ICH studyShuhei Ikeda, Yusuke Yakushiji, Jun Tanaka, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 27, 2026
Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular DiseaseSohei Yoshimura, Kaori Miwa, Masatoshi Koga, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2022
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical TrialMasatoshi Koga, Manabu Inoue, Kaori Miwa, et al.
Pageof 12